These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 21905205)

  • 1. Total synthesis and functional analysis of non-ribosomal peptides.
    Inoue M
    Chem Rec; 2011 Sep; 11(5):284-94. PubMed ID: 21905205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural trends among second-generation voltage-gated sodium channel blockers.
    Kemp MI
    Prog Med Chem; 2010; 49():81-111. PubMed ID: 20855039
    [No Abstract]   [Full Text] [Related]  

  • 3. The bulky side chain of antillatoxin is important for potent toxicity: rational design of photoresponsive cytotoxins based on SAR studies.
    Okura K; Matsuoka S; Inoue M
    Chem Commun (Camb); 2013 Sep; 49(73):8024-6. PubMed ID: 23903352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The twisted side chain of antillatoxin is important for potent toxicity: total synthesis and biological evaluation of antillatoxin and analogues.
    Okura K; Matsuoka S; Goto R; Inoue M
    Angew Chem Int Ed Engl; 2010; 49(2):329-32. PubMed ID: 19998300
    [No Abstract]   [Full Text] [Related]  

  • 5. Antillatoxin is a sodium channel activator that displays unique efficacy in heterologously expressed rNav1.2, rNav1.4 and rNav1.5 α subunits.
    Cao Z; Gerwick WH; Murray TF
    BMC Neurosci; 2010 Dec; 11():154. PubMed ID: 21156065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of (S)-jamaicamide C carboxylic acid.
    Graf KM; Tabor MG; Brown ML; Paige M
    Org Lett; 2009 Dec; 11(23):5382-5. PubMed ID: 19943696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2,4(5)-Diarylimidazoles: synthesis and biological evaluation of a new class of sodium channel blockers against hNa(v)1.2.
    Rivara M; Baheti AR; Fantini M; Cocconcelli G; Ghiron C; Kalmar CL; Singh N; Merrick EC; Patel MK; Zuliani V
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5460-2. PubMed ID: 18818069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical construction and structural permutation of neurotoxic natural product, antillatoxin: importance of the three-dimensional structure of the bulky side chain.
    Inoue M
    Proc Jpn Acad Ser B Phys Biol Sci; 2014; 90(2):56-66. PubMed ID: 24522155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical construction and structural permutation of potent cytotoxin polytheonamide B: discovery of artificial peptides with distinct functions.
    Itoh H; Inoue M
    Acc Chem Res; 2013 Jul; 46(7):1567-78. PubMed ID: 23488446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Four novel tarantula toxins as selective modulators of voltage-gated sodium channel subtypes.
    Bosmans F; Rash L; Zhu S; Diochot S; Lazdunski M; Escoubas P; Tytgat J
    Mol Pharmacol; 2006 Feb; 69(2):419-29. PubMed ID: 16267209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels.
    Catterall WA; Goldin AL; Waxman SG
    Pharmacol Rev; 2005 Dec; 57(4):397-409. PubMed ID: 16382098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and functional analysis of dansylated polytheonamide mimic: an artificial peptide ion channel.
    Itoh H; Matsuoka S; Kreir M; Inoue M
    J Am Chem Soc; 2012 Aug; 134(34):14011-8. PubMed ID: 22861006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solution structure of Jingzhaotoxin-III, a peptide toxin inhibiting both Nav1.5 and Kv2.1 channels.
    Liao Z; Yuan C; Peng K; Xiao Y; Liang S
    Toxicon; 2007 Jul; 50(1):135-43. PubMed ID: 17481690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ProTx-I and ProTx-II: gating modifiers of voltage-gated sodium channels.
    Priest BT; Blumenthal KM; Smith JJ; Warren VA; Smith MM
    Toxicon; 2007 Feb; 49(2):194-201. PubMed ID: 17087985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and in vitro evaluation of 2,4-diamino-1,3,5-triazine derivatives as neuronal voltage-gated sodium channel blockers.
    Ma X; Poon TY; Wong PT; Chui WK
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5644-7. PubMed ID: 19716698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing gating mechanisms of sodium channels using pore blockers.
    Goldschen-Ohm MP; Chanda B
    Handb Exp Pharmacol; 2014; 221():183-201. PubMed ID: 24737237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of hermitamides A and B as human voltage-gated sodium channel blockers.
    De Oliveira EO; Graf KM; Patel MK; Baheti A; Kong HS; MacArthur LH; Dakshanamurthy S; Wang K; Brown ML; Paige M
    Bioorg Med Chem; 2011 Jul; 19(14):4322-9. PubMed ID: 21683602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of non-amidine inhibitors of acid-sensing ion channel-3 (ASIC3).
    Kuduk SD; Chang RK; Di Marco CN; Dipardo RM; Cook SP; Cato MJ; Jovanovska A; Urban MO; Leitl M; Spencer RH; Kane SA; Hartman GD; Bilodeau MT
    Bioorg Med Chem Lett; 2011 Jul; 21(14):4255-8. PubMed ID: 21669528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Voltage-gated sodium channel blockers for the treatment of neuropathic pain.
    Cummins TR; Rush AM
    Expert Rev Neurother; 2007 Nov; 7(11):1597-612. PubMed ID: 17997706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Actions of sea anemone type 1 neurotoxins on voltage-gated sodium channel isoforms.
    Wanke E; Zaharenko AJ; Redaelli E; Schiavon E
    Toxicon; 2009 Dec; 54(8):1102-11. PubMed ID: 19393679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.